Investment Opportunity in True North Fund VII
Focus Sectors: Healthcare
Experience & Performance
Evaluated
Over 500 deals
Deployed
Exits
$680m across 14 deals
8 deals (incl. partial)
Realized Returns on Exits¹
2.6x MoIC | 30%+ Gross IRR
Network
Roster of 100+ CEOs/ CXOs
M
Extensive footprint across the spectrum
Healthcare
Delivery
M
A
CARE
HEALTHCAR
Manipal
Hospitals
KIMSHEALTH
HOSPITALS
cloudnine
LIFE'S ONE!
Biotech
Bid
Biocon
Biocon Biologics Anthem
Domestic
Formulations
Health
Insurance/TPA
InteGrace
BioSciences
Medical
Devices
TRIVITRON
HEALTHCARE
speaking your language
TTK HEALTHCARE TPA
PRIVATE LIMITED
Contract
Research
Syngene
Biocon company
Org Building: Worked with promoters to hire a senior leadership team
Strategizing growth plan: Helped co develop a growth plan for expansion across
different formats (clinics, pharmacies and hospitals) & evaluate acquisitions
At investment: 16 clinics, 19 pharmacies, 3 hospitals, $7m EBITDA
At exit: 100+ clinics, 200+ pharmacies, 19 hospitals, $123m EBITDA
Biocon
Syngene
Biocon company
Building Long Term relationships (like the Biocon Group)
Building admired businesses through collaboration
True North assisted in listing of both Biocon & Syngene on Indian stock
exchanges; Exit through IPO & open market sale
Delivered Return Profile on Exits 12
Syngene
Diversified Exit Routes
IRR: >25%
A Biocon company
M
HEALTHCARE (TN-III)
IPOs/Public
Market Sale
Biocon
OM
M
HEALTHCA
Syngene
A Biocon company
IRR: 15%-25%
Manipal
Hospitals
LIFE'S ON
InteGrace
Strategic
Sale
Manipal
Hospitals
TTK HEALTHCARE TPA
PRIVATE LIMITED
(TN-III & TN-IV)
TRIVITRON
HEALTHCARE
speaking your language
LIFE'S ON!
Confidential
IRR: <15%
1Returns before fees, expenses &
Copyrights Reserved©GP share of Profits
TRIVITRON
HEALTHCARE
speaking your language
M
HEALTHCARE (TN-IV & TN-V)
Financial
Sale
InteGrace
2Represents exits on investments above INR 50 Cr
Above information captures investments managed & advised by TN
15
truenorth
0
For ICICI Securities Clients OnlyView entire presentation